Literature DB >> 18293457

Stairs climbing test with pulse oximetry as predictor of early postoperative complications in functionally impaired patients with lung cancer and elective lung surgery: prospective trial of consecutive series of patients.

Igor Nikolić1, Visnja Majerić-Kogler, Davor Plavec, Ivana Maloca, Zoran Slobodnjak.   

Abstract

AIM: To test the predictive value of stairs climbing test for the development of postoperative complications in lung cancer patients with forced expiratory volume in one second (FEV1)<2 L, selected for an elective lung surgery.
METHODS: The prospective study was conducted in 101 consecutive patients with an FEV1<2 L selected for elective lung surgery for lung cancer. Preoperative examination included medical history and physical examination, lung function testing, electrocardiography, laboratory testing, and chest radiography. All patients underwent stairs climbing with pulse oximetry before the operation with the number of steps climbed and the time to complete the test recorded. Oxygen saturation and pulse rate were measured every 20 steps. Data on postoperative complications including oxygen use, prolonged mechanical ventilation, and early postoperative mortality were collected.
RESULTS: Eighty-seven of 101 patients (86%) had at least one postoperative complication. The type of surgery was significantly associated with postoperative complications (25.5% patients with lobectomy had no early postoperative complications), while age, gender, smoking status, postoperative oxygenation, and artificial ventilation were not. There were more postoperative complications in more extensive and serious types of surgery (P<0.001). The stairs climbing test produced a significant decrease in oxygen saturation (-1%) and increase in pulse rate (by 10/min) for every 20 steps climbed. The stairs climbing test was predictive for postoperative complications only in lobectomy group, with the best predictive parameter being the quotient of oxygen saturation after 40 steps and test duration (positive likelihood ratio [LR], 2.4; 95% confidence interval [CI], 1.71-3.38; negative LR, 0.53; 95% CI, 0.38-0.76). In patients with other types of surgery the only significant predictive parameter for incident severe postoperative complications was the number of days on artificial ventilation (P=0.006).
CONCLUSION: Stairs climbing test should be done in routine clinical practice as a standard test for risk assessment and prediction of the development of postoperative complications in lung cancer patients selected for elective surgery (lobectomy). Comparative to spirometry, it detects serious disorders in oxygen transport that are a baseline for a later development of cardiopulmonary postoperative complications and mortality in this subgroup of patients.

Entities:  

Mesh:

Year:  2008        PMID: 18293457      PMCID: PMC2269232          DOI: 10.3325/cmj.2008.1.50

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  22 in total

1.  Noninvasive ventilatory support after lung resectional surgery.

Authors:  R Aguiló; B Togores; S Pons; M Rubí; F Barbé; A G Agustí
Journal:  Chest       Date:  1997-07       Impact factor: 9.410

2.  Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection.

Authors:  D A Holden; T W Rice; K Stelmach; D P Meeker
Journal:  Chest       Date:  1992-12       Impact factor: 9.410

3.  What do we know about causes of sex differences in mortality? A review of the literature.

Authors:  I Waldron
Journal:  Popul Bull UN       Date:  1985

4.  Cardiac arrhythmias in the older age group following thoracic surgery.

Authors:  A KROSNICK; F WASSERMAN
Journal:  Am J Med Sci       Date:  1955-11       Impact factor: 2.378

5.  The diagnostic odds ratio: a single indicator of test performance.

Authors:  Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt
Journal:  J Clin Epidemiol       Date:  2003-11       Impact factor: 6.437

Review 6.  The evolving role of exercise testing prior to lung resection.

Authors:  G N Olsen
Journal:  Chest       Date:  1989-01       Impact factor: 9.410

7.  Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment.

Authors:  Pierre Magdeleinat; Agathe Seguin; Marco Alifano; Souheil Boubia; Jean-François Regnard
Journal:  Eur J Cardiothorac Surg       Date:  2005-03-02       Impact factor: 4.191

8.  Prognostic factors for complications following pulmonary resection: pre-albumin analysis, time on mechanical ventilation, and other factors.

Authors:  Renata Cristiane Gennari Bianchi; Juliana Nalin de Souza; Carolina de Almeida Giaciani; Neucy Fenalti Hoehr; Ivan Felizardo Contrera Toro
Journal:  J Bras Pneumol       Date:  2006 Nov-Dec       Impact factor: 2.624

9.  Time trends and survival after operations for primary lung cancer from 1976 through 1990.

Authors:  H Wada; F Tanaka; K Yanagihara; T Ariyasu; T Fukuse; H Yokomise; K Inui; H Mizuno; O Ike; S Hitomi
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

Review 10.  Role of exercise stress testing in preoperative evaluation of patients for lung resection.

Authors:  E M Gilbreth; I M Weisman
Journal:  Clin Chest Med       Date:  1994-06       Impact factor: 2.878

View more
  2 in total

Review 1.  Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties.

Authors:  Catherine L Granger; Christine F McDonald; Selina M Parry; Cristino C Oliveira; Linda Denehy
Journal:  BMC Cancer       Date:  2013-03-20       Impact factor: 4.430

2.  Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis.

Authors:  Fairuz Boujibar; André Gillibert; Francis Edouard Gravier; Timothée Gillot; Tristan Bonnevie; Antoine Cuvelier; Jean-Marc Baste
Journal:  Thorax       Date:  2020-07-10       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.